CE vs VXRT · rev $10.28B vs rev $28.7M
Celanese Corporation (CE) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
CE currently screens at market cap $5.92B. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the CE and VXRT stock pages for the full models.
Not investment advice.